Table 3.
Ten most frequently reported reactions according to age group
| a. < 10 years (n = 18,022) | |
|---|---|
| Seizure, n (%) | 390 (2.2) |
| Anaphylactic reaction, n (%) | 374 (2.1) |
| Abnormal behavior, n (%) | 374 (2.1) |
| Hepatic function abnormal, n (%) | 336 (1.9) |
| Pyrexia, n (%) | 319 (1.8) |
| Anaphylactic shock, n (%) | 271 (1.5) |
| Stevens-Johnson syndrome, n (%) | 246 (1.4) |
| Rash, n (%) | 229 (1.3) |
| Erythema multiforme, n (%) | 195 (1.1) |
| Drug eruption, n (%) | 156 (0.9) |
| b. 10–19 years (n = 15,157) | |
| Abnormal behavior, n (%) | 419 (2.8) |
| Anaphylactic shock, n (%) | 353 (2.3) |
| Anaphylactic reaction, n (%) | 333 (2.2) |
| Pyrexia, n (%) | 236 (1.6) |
| Seizure, n (%) | 223 (1.5) |
| Hepatic function abnormal, n (%) | 220 (1.5) |
| Stevens-Johnson syndrome, n (%) | 175 (1.2) |
| Drug reaction with eosinophilia and systemic symptoms, n (%) | 171 (1.1) |
| Pancreatitis acute, n (%) | 170 (1.1) |
| Rash, n (%) | 169 (1.1) |
Note: The terms are as described in Japanese version 21.0 of MedDRA®